iRhythm projects revenue for the full year 2023 to grow approximately 19% compared to prior year results, ranging from approximately $487.5 million to $490 million. Gross margin for the full year 2023 is expected to range from 68% to 69% and adjusted operating expenses are expected to range between $425 million and $429 million. Adjusted EBITDA margin for the full year 2023 is expected to range from approximately 0% to 0.5% of revenues.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IRTC:
- iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
- iRhythm price target lowered to $100 from $138 at Truist
- iRhythm price target lowered to $135 from $149 at Morgan Stanley
- iRhythm price target lowered to $100 from $115 at Citi
- iRhythm launches next generation Zio monitor, enhanced Zio service
